Cargando…
Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments
BACKGROUND: High-risk neuroblastoma has an overall five-year survival of less than 40%, indicating a need for new treatment strategies such as angiogenesis inhibition. Recent studies have shown that chemotherapeutic drugs can inhibit angiogenesis if administered in a continuous schedule. The aim of...
Autores principales: | Fuchs, Dieter, Christofferson, Rolf, Stridsberg, Mats, Lindhagen, Elin, Azarbayjani, Faranak |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667491/ https://www.ncbi.nlm.nih.gov/pubmed/19284605 http://dx.doi.org/10.1186/1479-5876-7-16 |
Ejemplares similares
-
Development and characterization of a human orthotopic neuroblastoma xenograft
por: Stewart, Elizabeth, et al.
Publicado: (2015) -
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
por: Li, Nan, et al.
Publicado: (2021) -
Different tumorigenicity and distinct metastasis and gene signature between orthotopic and subcutaneous neuroblastoma xenografted mice
por: Han, Rui, et al.
Publicado: (2022) -
Altered Expression of Somatostatin Receptors in Pancreatic Islets from NOD Mice Cultured at Different Glucose Concentrations In Vitro and in Islets Transplanted to Diabetic NOD Mice In Vivo
por: Ludvigsen, Eva, et al.
Publicado: (2011) -
Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model
por: Sever, ReidAnn E., et al.
Publicado: (2023)